Capstone Therapeutics: Clinical Trials

3 completed, 1 terminated. 4 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	4	Completed 3, Terminated 1

Follow Capstone Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars AZX100 Drug Product, Placebo - Scar Prevention, Scar Reduction	Phase 2	Completed	Capstone Therapeutics	59	2009-05-01	2012-10-11
A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars AZX100 Drug Product, Placebo - Scar Prevention, Scar Reduction	Phase 2	Completed	Capstone Therapeutics	59	2009-03-01	2012-10-11
A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients Placebo, AZX100 - Scar Prevention, Scar Reduction	Phase 2	Completed	Capstone Therapeutics	150	2009-01-01	2012-10-11
A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist Chrysalin, Placebo - Radius Fracture	Phase 2	Terminated	Capstone Therapeutics	274	2004-11-01	2010-08-24

Conditions studied

Cicatrix (3)  ·  Keloid (2)  ·  Fractures, Bone (1)  ·  Radius Fractures (1)

Interventions

AZX 100 (1)  ·  rusalatide acetate (1)

Countries

United States (4)

Top investigators

James Ryaby, Ph.D. (1)